Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcella Kaddoura

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Blood Cancer Discovery|January 4, 2024
Emerging Strategies for the Prevention of Immune Toxicities Associated with T cell-Engaging Cancer TherapiesAndrew Kowalski, Jill Lykon, Benjamin Diamond, et al.
Blood Advances|July 1, 2025
Tocilizumab Prophylaxis for Patients with Multiple Myeloma Treated with Bispecific AntibodiesAndrew Kowalski, Jillian Lykon, Benjamin T Diamond, et al.
The Annals of Otology, Rhinology, and Laryngology|May 13, 2014
UM-SCC-103: a unique tongue cancer cell line that recapitulates the tumorigenic stem cell population of the primary tumorJohn H Owen, Samantha J Hauff, Alice L Tang, et al.
American Journal of Hematology|January 3, 2022
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcomeMarcella Kaddoura, Moritz Binder, David Dingli, et al.
Blood Advances|July 9, 2021
Prognostic impact of posttransplant FDG PET/CT scan in multiple myelomaMarcella Kaddoura, David Dingli, Francis K Buadi, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignanciesBenjamin Diamond, Dhanvantri Chahar, Michael D Jain, et al.
Blood Cancer Discovery|May 22, 2025
Mutagenic impact and evolutionary influence of chemo-radiotherapy in hematologic malignanciesBenjamin Diamond, Dhanvantri Chahar, Michael D Jain, et al.
Blood|May 10, 2024
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myelomaAnthony M Cirrincione, Alexandra M Poos, Bachisio Ziccheddu, et al.
Blood|June 10, 2025
Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myelomaBenjamin T Diamond, Linda B Baughn, Mansour Poorebrahim, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple MyelomaFrancesco Maura, Marcella Kaddoura, Alexandra M Poos, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Blood Cancer Discovery|January 4, 2024
Emerging Strategies for the Prevention of Immune Toxicities Associated with T cell-Engaging Cancer TherapiesAndrew Kowalski, Jill Lykon, Benjamin Diamond, et al.
Blood Advances|July 1, 2025
Tocilizumab Prophylaxis for Patients with Multiple Myeloma Treated with Bispecific AntibodiesAndrew Kowalski, Jillian Lykon, Benjamin T Diamond, et al.
The Annals of Otology, Rhinology, and Laryngology|May 13, 2014
UM-SCC-103: a unique tongue cancer cell line that recapitulates the tumorigenic stem cell population of the primary tumorJohn H Owen, Samantha J Hauff, Alice L Tang, et al.
American Journal of Hematology|January 3, 2022
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcomeMarcella Kaddoura, Moritz Binder, David Dingli, et al.
Blood Advances|July 9, 2021
Prognostic impact of posttransplant FDG PET/CT scan in multiple myelomaMarcella Kaddoura, David Dingli, Francis K Buadi, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Mutagenic impact and evolutionary influence of radiotherapy in hematologic malignanciesBenjamin Diamond, Dhanvantri Chahar, Michael D Jain, et al.
Blood Cancer Discovery|May 22, 2025
Mutagenic impact and evolutionary influence of chemo-radiotherapy in hematologic malignanciesBenjamin Diamond, Dhanvantri Chahar, Michael D Jain, et al.
Blood|May 10, 2024
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myelomaAnthony M Cirrincione, Alexandra M Poos, Bachisio Ziccheddu, et al.
Blood|June 10, 2025
Biallelic antigen escape is a mechanism of resistance to anti-CD38 antibodies in multiple myelomaBenjamin T Diamond, Linda B Baughn, Mansour Poorebrahim, et al.
Biorxiv : the Preprint Server for Biology|September 16, 2024
Temporal Genomic Dynamics Shape Clinical Trajectory in Multiple MyelomaFrancesco Maura, Marcella Kaddoura, Alexandra M Poos, et al.
Pageof 2